Nifty

:

24346.70

Sensex

:

80501.99

12.50 (0.05%)
259.75 (0.32%)

Login

Nifty
Sensex

:
:

24346.70
80501.99

12.50 (0.05%)
259.75 (0.32%)

Tatva Chintan Pharma Chem Ltd.

Chemicals

Rating :

N/A

BSE: 543321 | NSE: TATVA

Watchlist

NSE BSE

770.45

06-Feb-2025

Open
High
Low
Previous Close

788.30
795.75
764.15
784.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

15733
122.02
1283.70
621.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,646.92
288.28
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,669.21
0.14%
2.23

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.06
8.37
-3.19

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.52
4.35
-8.82

PAT CAGR (%)

10 Years
5 Years
3 Years

17.91
-4.29
-31.85

P:E (Median)

8 Years
5 Years
3 Years

-
-
83.17

P:BV (Average)

8 Years
5 Years
3 Years

-
-
6.14

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
45.43

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 107.65 93.93 14.61% 84.00 86.07 -2.41% 80.96 92.57 -12.54% 93.81 106.10 -11.58%
Expenses 99.75 79.73 25.11% 78.35 73.76 6.22% 76.36 71.83 6.31% 86.11 86.49 -0.44%
EBITDA 7.90 14.20 -44.37% 5.65 12.31 -54.10% 4.60 20.74 -77.82% 7.70 19.61 -60.73%
EBIDTM 7.34% 15.12% 6.72% 14.31% 5.68% 22.41% 8.20% 18.48%
Other Income 1.29 4.53 -71.52% 0.04 1.21 -96.69% 0.81 0.76 6.58% 1.42 1.02 39.22%
Interest 0.39 0.22 77.27% 0.42 0.38 10.53% 0.17 3.01 -94.35% 0.31 2.90 -89.31%
Depreciation 7.26 6.23 16.53% 6.92 6.58 5.17% 6.81 6.78 0.44% 6.66 6.01 10.82%
PBT 1.55 12.28 -87.38% -1.65 6.56 - -1.58 11.71 - 2.14 11.72 -81.74%
Tax 0.46 4.03 -88.59% -0.49 1.91 - -0.47 3.50 - 0.63 3.47 -81.84%
PAT 1.09 8.25 -86.79% -1.17 4.65 - -1.11 8.20 - 1.51 8.25 -81.70%
PATM 1.02% 8.78% -1.39% 5.40% -1.37% 8.86% 1.61% 7.77%
EPS 0.47 3.52 -86.65% -0.50 1.99 - -0.47 3.51 - 0.64 3.52 -81.82%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 107.86 98.27 9.76% 85.90 84.21 2.01% 83.49 96.67 -13.63% 105.46 114.36 -7.78%
Expenses 98.91 82.66 19.66% 78.84 73.21 7.69% 77.90 76.42 1.94% 92.85 93.02 -0.18%
EBITDA 8.95 15.61 -42.66% 7.06 10.99 -35.76% 5.59 20.25 -72.40% 12.62 21.34 -40.86%
EBIDTM 8.30% 15.88% 8.22% 13.06% 6.69% 20.95% 11.96% 18.66%
Other Income 0.72 4.53 -84.11% 0.04 1.21 -96.69% 0.38 0.76 -50.00% 1.17 1.02 14.71%
Interest 0.39 0.21 85.71% 0.42 0.38 10.53% 0.17 3.01 -94.35% 0.31 2.93 -89.42%
Depreciation 7.26 6.23 16.53% 6.92 6.58 5.17% 6.81 6.78 0.44% 6.67 6.01 10.98%
PBT 2.03 13.69 -85.17% -0.24 5.24 - -1.02 11.21 - 6.81 13.42 -49.25%
Tax 1.00 4.08 -75.49% -0.37 1.79 - -0.36 3.43 - 1.60 3.92 -59.18%
PAT 1.03 9.61 -89.28% 0.14 3.45 -95.94% -0.66 7.78 - 5.21 9.50 -45.16%
PATM 0.95% 9.78% 0.16% 4.10% -0.80% 8.05% 4.94% 8.31%
EPS 0.44 4.11 -89.29% 0.06 1.48 -95.95% -0.28 3.33 - 2.23 4.29 -48.02%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 366.42 378.68 403.04 427.81 291.19 253.84 202.90 89.93 101.57 80.35 52.80 Net Sales Growth -3.24% -6.04% -5.79% 46.92% 14.71% 25.11% 125.62% -11.46% 26.41% 52.18% Cost Of Goods Sold 197.67 168.04 222.33 196.45 148.33 130.13 115.18 47.95 63.68 49.91 0.00 Gross Profit 168.75 210.64 180.72 231.36 142.86 123.71 87.72 41.98 37.89 30.43 52.80 GP Margin 46.05% 55.62% 44.84% 54.08% 49.06% 48.74% 43.23% 46.68% 37.30% 37.87% 100% Total Expenditure 340.57 311.66 348.23 321.81 225.79 201.14 169.71 75.09 90.30 69.62 52.89 Power & Fuel Cost - 34.78 23.61 22.62 9.92 8.96 6.25 1.53 3.25 2.91 0.00 % Of Sales - 9.18% 5.86% 5.29% 3.41% 3.53% 3.08% 1.70% 3.20% 3.62% 0% Employee Cost - 54.76 41.21 30.82 23.80 20.53 16.31 6.97 8.13 4.39 0.00 % Of Sales - 14.46% 10.22% 7.20% 8.17% 8.09% 8.04% 7.75% 8.00% 5.46% 0% Manufacturing Exp. - 32.24 30.72 42.30 26.38 23.99 13.88 3.18 6.37 4.28 0.00 % Of Sales - 8.51% 7.62% 9.89% 9.06% 9.45% 6.84% 3.54% 6.27% 5.33% 0% General & Admin Exp. - 10.99 10.33 9.10 6.88 5.96 7.57 3.53 1.71 1.40 52.80 % Of Sales - 2.90% 2.56% 2.13% 2.36% 2.35% 3.73% 3.93% 1.68% 1.74% 100% Selling & Distn. Exp. - 9.18 15.61 19.52 9.72 9.66 8.56 0.00 1.48 1.61 0.00 % Of Sales - 2.42% 3.87% 4.56% 3.34% 3.81% 4.22% 0% 1.46% 2.00% 0% Miscellaneous Exp. - 1.67 4.42 1.01 0.76 1.91 1.96 11.93 5.68 5.12 0.00 % Of Sales - 0.44% 1.10% 0.24% 0.26% 0.75% 0.97% 13.27% 5.59% 6.37% 0.17% EBITDA 25.85 67.02 54.81 106.00 65.40 52.70 33.19 14.84 11.27 10.73 -0.09 EBITDA Margin 7.05% 17.70% 13.60% 24.78% 22.46% 20.76% 16.36% 16.50% 11.10% 13.35% -0.17% Other Income 3.56 7.51 5.68 10.63 5.10 0.56 0.44 0.78 1.43 0.13 5.47 Interest 1.29 6.66 8.52 5.19 4.41 4.25 3.94 1.79 2.47 2.13 1.92 Depreciation 27.65 25.60 9.55 8.18 6.73 4.79 4.01 2.19 1.86 0.83 0.75 PBT 0.46 42.27 42.42 103.27 59.35 44.22 25.68 11.63 8.37 7.89 2.71 Tax 0.13 12.92 -1.63 7.28 7.99 9.25 6.24 4.21 2.72 2.67 0.89 Tax Rate 28.26% 30.57% -4.20% 7.05% 13.46% 20.92% 23.61% 36.20% 32.50% 33.84% 32.84% PAT 0.32 29.35 40.47 95.99 51.36 34.96 20.19 7.43 5.65 5.23 1.82 PAT before Minority Interest 0.32 29.35 40.47 95.99 51.36 34.96 20.19 7.43 5.65 5.23 1.82 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.09% 7.75% 10.04% 22.44% 17.64% 13.77% 9.95% 8.26% 5.56% 6.51% 3.45% PAT Growth -98.91% -27.48% -57.84% 86.90% 46.91% 73.16% 171.74% 31.50% 8.03% 187.36% EPS 0.14 12.54 17.29 41.02 21.95 14.94 8.63 3.18 2.41 2.24 0.78

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 382.71 393.50 423.61 433.65 300.36 263.24 206.31 Net Sales Growth -2.74% -7.11% -2.32% 44.38% 14.10% 27.59% Cost Of Goods Sold 198.94 174.18 226.10 194.64 152.00 132.77 114.24 Gross Profit 183.77 219.32 197.51 239.01 148.35 130.47 92.07 GP Margin 48.02% 55.74% 46.63% 55.12% 49.39% 49.56% 44.63% Total Expenditure 348.50 325.11 362.83 325.13 233.68 207.96 172.19 Power & Fuel Cost - 34.78 23.61 22.62 9.92 8.96 6.25 % Of Sales - 8.84% 5.57% 5.22% 3.30% 3.40% 3.03% Employee Cost - 54.76 41.21 30.82 23.80 20.53 16.31 % Of Sales - 13.92% 9.73% 7.11% 7.92% 7.80% 7.91% Manufacturing Exp. - 32.24 30.72 42.30 26.38 24.00 13.88 % Of Sales - 8.19% 7.25% 9.75% 8.78% 9.12% 6.73% General & Admin Exp. - 11.82 11.29 9.76 7.21 6.58 8.06 % Of Sales - 3.00% 2.67% 2.25% 2.40% 2.50% 3.91% Selling & Distn. Exp. - 14.67 20.95 23.87 13.56 11.88 11.13 % Of Sales - 3.73% 4.95% 5.50% 4.51% 4.51% 5.39% Miscellaneous Exp. - 2.67 8.94 1.13 0.80 3.24 2.32 % Of Sales - 0.68% 2.11% 0.26% 0.27% 1.23% 1.12% EBITDA 34.22 68.39 60.78 108.52 66.68 55.28 34.12 EBITDA Margin 8.94% 17.38% 14.35% 25.02% 22.20% 21.00% 16.54% Other Income 2.31 7.51 5.74 9.02 5.20 1.38 0.49 Interest 1.29 6.73 8.60 5.23 4.45 4.27 3.95 Depreciation 27.66 25.61 9.55 8.18 6.73 4.79 4.02 PBT 7.58 43.57 48.37 104.12 60.70 47.60 26.64 Tax 1.87 13.21 -0.71 8.25 8.43 9.81 6.85 Tax Rate 24.67% 30.32% -1.59% 7.92% 13.89% 20.61% 25.01% PAT 5.72 30.35 45.49 95.87 52.26 37.79 20.54 PAT before Minority Interest 5.72 30.35 45.49 95.87 52.26 37.79 20.54 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.49% 7.71% 10.74% 22.11% 17.40% 14.36% 9.96% PAT Growth -81.15% -33.28% -52.55% 83.45% 38.29% 83.98% EPS 2.44 12.97 19.44 40.97 22.33 16.15 8.78

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 725.88 504.78 468.88 161.94 114.45 79.64 15.93 10.36 8.27 6.13 Share Capital 23.39 22.16 22.16 20.09 8.04 8.04 4.36 4.00 3.73 3.41 Total Reserves 702.49 482.62 446.71 141.85 106.41 71.60 11.57 6.36 4.54 2.72 Non-Current Liabilities -10.32 -11.03 5.06 30.82 43.59 35.16 8.29 7.49 7.89 4.45 Secured Loans 0.64 4.23 13.11 26.76 38.71 31.52 1.71 1.76 2.56 1.35 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 5.29 4.58 4.37 2.35 Long Term Provisions 1.33 1.15 0.65 0.55 0.40 0.29 0.00 0.00 0.00 0.00 Current Liabilities 94.56 246.58 193.55 127.08 87.26 72.57 28.54 20.79 17.65 12.20 Trade Payables 44.26 31.61 44.06 47.04 31.23 22.05 14.28 6.95 7.03 4.37 Other Current Liabilities 32.59 56.55 56.66 20.39 15.49 10.57 0.46 0.54 0.44 0.52 Short Term Borrowings 10.00 156.21 92.47 49.29 40.49 39.91 13.80 13.30 10.16 7.30 Short Term Provisions 7.71 2.21 0.37 10.35 0.06 0.04 0.00 0.00 0.01 0.01 Total Liabilities 810.12 740.33 667.49 319.84 245.30 187.37 52.76 38.64 33.81 22.78 Net Block 426.87 196.22 159.61 120.45 111.18 66.71 12.20 11.02 10.91 9.00 Gross Block 488.00 231.75 186.14 138.88 122.48 73.45 15.71 13.97 13.15 10.63 Accumulated Depreciation 61.13 35.53 26.53 18.43 11.30 6.74 3.51 2.95 2.24 1.63 Non Current Assets 509.16 430.85 214.37 131.22 116.90 73.78 15.09 13.80 13.36 9.03 Capital Work in Progress 76.54 230.74 51.49 9.81 4.89 6.04 0.20 0.00 0.01 0.00 Non Current Investment 0.67 0.67 0.67 0.67 0.67 0.67 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 4.26 2.66 2.09 0.30 0.17 0.38 2.68 2.77 2.45 0.03 Other Non Current Assets 0.83 0.55 0.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 300.95 309.49 453.12 188.61 128.40 113.58 37.44 24.69 20.39 13.73 Current Investments 10.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 144.11 151.45 160.69 68.36 58.72 31.06 10.86 7.40 6.77 6.53 Sundry Debtors 67.95 90.04 61.60 90.34 50.97 44.65 18.89 11.99 8.64 4.42 Cash & Bank 36.97 38.58 174.74 3.59 9.82 15.66 2.58 1.54 1.23 0.62 Other Current Assets 41.87 5.09 5.37 6.41 8.89 22.20 5.12 3.76 3.75 2.16 Short Term Loans & Adv. 35.19 24.32 50.72 19.92 6.04 18.55 5.12 3.76 3.75 2.16 Net Current Assets 206.39 62.91 259.57 61.54 41.14 41.01 8.91 3.90 2.74 1.53 Total Assets 810.11 740.34 667.49 319.83 245.30 187.36 52.75 38.65 33.81 22.78

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 737.08 514.79 473.09 165.96 117.69 79.70 Share Capital 23.39 22.16 22.16 20.09 8.04 8.04 Total Reserves 713.69 492.63 450.92 145.88 109.66 71.67 Non-Current Liabilities -10.32 -11.03 5.06 30.82 43.59 35.16 Secured Loans 0.64 4.23 13.11 26.76 38.71 31.52 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.33 1.15 0.65 0.55 0.40 0.29 Current Liabilities 87.01 240.57 171.20 128.41 87.65 72.65 Trade Payables 45.03 32.19 44.51 47.48 31.61 22.13 Other Current Liabilities 24.19 49.75 33.01 20.74 15.49 10.57 Short Term Borrowings 10.00 156.21 92.47 49.29 40.49 39.91 Short Term Provisions 7.78 2.43 1.20 10.89 0.06 0.04 Total Liabilities 813.77 744.33 649.35 325.19 248.93 187.51 Net Block 426.89 196.25 159.61 120.45 111.18 66.71 Gross Block 488.02 231.78 186.14 138.88 122.48 73.46 Accumulated Depreciation 61.14 35.53 26.53 18.44 11.30 6.74 Non Current Assets 508.51 430.20 213.71 130.55 116.24 73.12 Capital Work in Progress 76.54 230.74 51.49 9.81 4.89 6.04 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 4.26 2.66 2.09 0.30 0.17 0.38 Other Non Current Assets 0.83 0.55 0.51 0.00 0.00 0.00 Current Assets 305.25 314.13 435.64 194.64 132.70 114.38 Current Investments 10.05 0.00 0.00 0.00 0.00 0.00 Inventories 152.77 162.50 169.96 72.02 63.55 35.59 Sundry Debtors 69.85 84.40 56.60 90.74 49.57 41.26 Cash & Bank 38.29 44.76 176.99 5.34 10.83 15.74 Other Current Assets 34.29 5.13 5.38 6.38 8.74 21.79 Short Term Loans & Adv. 27.49 17.34 26.72 20.16 5.89 18.14 Net Current Assets 218.24 73.56 264.44 66.23 45.05 41.73 Total Assets 813.76 744.33 649.35 325.19 248.94 187.50

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 102.78 23.73 19.76 18.91 24.64 7.87 3.29 2.50 0.00 0.00 PBT 42.27 38.83 103.27 59.35 44.22 26.43 7.89 2.71 0.00 0.00 Adjustment 28.17 15.82 9.64 6.92 8.20 7.49 1.89 1.66 0.00 0.00 Changes in Working Capital 40.58 -23.18 -75.18 -37.55 -20.40 -20.31 -3.97 -1.17 0.00 0.00 Cash after chg. in Working capital 111.02 31.47 37.73 28.73 32.02 13.61 5.82 3.20 0.00 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -8.24 -7.74 -17.97 -9.82 -7.39 -5.74 -2.53 -0.70 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -120.54 -101.12 -196.69 -20.61 -40.18 -16.77 -2.58 -1.08 0.00 0.00 Net Fixed Assets -102.05 -224.86 -88.94 -21.32 -47.88 -63.58 -1.94 -0.81 -2.53 -0.64 Net Investments -10.05 0.00 0.00 0.00 0.00 -0.67 0.00 0.00 0.00 0.00 Others -8.44 123.74 -107.75 0.71 7.70 47.48 -0.64 -0.27 2.53 0.64 Cash from Financing Activity 30.54 37.81 235.01 -4.72 9.70 17.40 0.33 -1.10 0.00 0.00 Net Cash Inflow / Outflow 12.78 -39.58 58.08 -6.42 -5.85 8.50 1.04 0.31 0.00 0.00 Opening Cash & Equivalents 21.19 60.77 2.73 9.15 15.66 7.17 1.54 1.23 0.00 0.00 Closing Cash & Equivalent 33.99 21.19 60.77 2.73 9.82 15.66 2.58 1.54 0.00 0.00

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 98.04 27.78 20.23 19.69 25.31 7.36 PBT 43.57 44.78 104.12 60.70 47.60 27.39 Adjustment 28.60 16.69 11.63 6.85 8.56 7.57 Changes in Working Capital 35.73 -24.40 -77.11 -38.04 -22.64 -21.66 Cash after chg. in Working capital 107.90 37.07 38.64 29.50 33.51 13.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.86 -9.29 -18.41 -9.81 -8.20 -5.95 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -120.54 -101.14 -196.69 -20.66 -40.18 -16.77 Net Fixed Assets -102.05 -224.86 -88.94 -21.32 -47.88 Net Investments -10.05 0.00 0.00 0.00 0.00 Others -8.44 123.72 -107.75 0.66 7.70 Cash from Financing Activity 30.52 37.80 235.01 -4.71 9.95 17.40 Net Cash Inflow / Outflow 8.02 -35.57 58.55 -5.67 -4.92 7.99 Opening Cash & Equivalents 27.36 63.02 4.48 10.16 15.74 7.76 Closing Cash & Equivalent 35.30 27.36 63.02 4.48 10.83 15.74

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 310.31 227.74 211.54 80.61 56.97 99.11 36.03 25.52 21.99 17.94 ROA 3.79% 5.75% 19.44% 18.18% 16.16% 12.10% 11.44% 5.02% 6.20% 3.56% ROE 4.77% 8.31% 30.43% 37.16% 36.03% 28.76% 40.35% 19.75% 24.48% 15.20% ROCE 6.91% 7.49% 25.79% 27.88% 26.78% 22.19% 29.77% 16.80% 21.57% 13.98% Fixed Asset Turnover 1.06 1.93 2.63 2.23 2.59 2.84 5.42 3.89 4.04 2.69 Receivable days 75.93 68.49 64.78 88.57 68.75 72.32 70.03 71.31 49.67 65.22 Inventory Days 142.05 140.96 97.66 79.65 64.54 49.92 41.43 48.99 50.55 81.51 Payable days 82.40 62.12 84.63 96.30 48.79 51.46 4651.92 3411.13 3207.32 3650.00 Cash Conversion Cycle 135.59 147.33 77.81 71.91 84.50 70.78 -4540.46 -3290.84 -3107.10 -3503.26 Total Debt/Equity 0.02 0.34 0.26 0.56 0.79 0.97 1.32 1.92 2.08 1.80 Interest Cover 7.35 5.56 20.90 14.45 11.40 7.71 4.98 2.41 2.43 2.13

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 315.10 232.25 213.44 82.62 58.59 99.19 ROA 3.90% 6.53% 19.68% 18.21% 17.32% 12.28% ROE 4.85% 9.21% 30.01% 36.85% 38.29% 28.95% ROCE 7.00% 8.35% 25.75% 28.04% 28.40% 22.78% Fixed Asset Turnover 1.10 2.03 2.67 2.30 2.69 2.88 Receivable days 71.34 60.72 61.98 85.26 62.97 64.50 Inventory Days 145.79 143.16 101.78 82.38 68.74 57.57 Payable days 80.91 61.91 86.25 94.96 48.09 50.05 Cash Conversion Cycle 136.22 141.97 77.51 72.67 83.61 72.03 Total Debt/Equity 0.02 0.33 0.25 0.54 0.77 0.97 Interest Cover 7.47 6.21 20.90 14.65 12.15 7.94

Top Investors:

nippon life india trustee ltd-a/c nippon india elss tax saver fund

goldman sachs funds - goldman sachs india equity portfolio

icici prudential smallcap fund

Annual Reports:

News Update:

Tatva Chintan Pharma - Quarterly Results
28th Jan 2025, 15:45 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback